Related Experiment Video
Updated: Jun 23, 2025

06:27
Wireless Telemetry Device Implantation in a Fontan Ovine Model for Continuous and Long-Term Hemodynamic Monitoring
Published on: May 2, 2025
127
Contemporary Management of the Failing Fontan.
Prashanth Venkatesh1, Hans Gao1, Islam Abudayyeh2
1Smidt Heart Institute, Department of Cardiology, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Journal of Clinical Medicine
|June 19, 2024
Summary
Adults with Fontan circulation, a complex congenital heart defect, face serious complications. This review details common Fontan circulatory failure issues and current management strategies for improved patient outcomes.
Area of Science:
- Cardiology
- Adult Congenital Heart Disease
- Cardiovascular Physiology
Background:
- Adult congenital heart disease (ACHD) patient numbers now exceed pediatric cases due to surgical advances and better survival rates.
- Fontan circulation is a complex congenital heart defect frequently seen in the adult ACHD population.
- Patients with Fontan circulation exhibit unique physiology, predisposing them to numerous complications.
Purpose of the Study:
- To review the common clinical presentations (phenotypes) of Fontan circulatory failure.
- To discuss contemporary management strategies for these Fontan failure phenotypes.
- To provide an updated overview for clinicians managing adult Fontan patients.
Main Methods:
- Literature review of contemporary studies and clinical guidelines.
- Synthesis of information on Fontan circulatory failure phenotypes.
- Analysis of current treatment approaches for Fontan-associated complications.
Main Results:
- Common phenotypes of Fontan circulatory failure include thrombosis, pulmonary vascular disease, heart failure, arrhythmias, valve regurgitation, and protein-losing enteropathy.
- Management strategies are tailored to specific phenotypes, involving medical, interventional, and surgical options.
- Advances in care have improved survival but necessitate ongoing vigilance for complications.
Conclusions:
- Fontan circulatory failure presents diverse phenotypes requiring specialized management in adult ACHD.
- Contemporary strategies focus on early recognition and multidisciplinary care to mitigate Fontan-associated risks.
- Continued research and clinical updates are crucial for optimizing long-term outcomes in Fontan survivors.
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
420
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
420
Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K

